- Business
- New Providence Acquisition Corp. III Units (NPACU) represents the publicly traded units of New Providence Acquisition Corp. III, a blank check company sponsored by New Providence Acquisition Corp., which focuses on effecting mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations with one or more businesses. The units consist of one share of Class A ordinary shares and one-half of one redeemable warrant, entitling the holder to purchase one share of Class A ordinary shares at $11.50 per share; the company targets opportunities primarily in the healthcare industry, with a preference for companies in biotechnology, pharmaceutical, medical devices, healthcare services, and healthcare information technology sectors. New Providence Acquisition Corp. III operates in the United States and was founded in 2022 with headquarters in New York, New York; it has no current operating subsidiaries or specified parent company relationships beyond its sponsor. No major recent partnerships, acquisitions, funding rounds, product launches, or strategic shifts have been publicly announced for the company within the last 1-2 years.